FDA Clarifies Safety Rules for Drug and Device Trials
Published Date: 12/16/2025
Notice
Summary
The FDA just released final guidance to help researchers safely report problems with new drugs and devices during studies. This update affects clinical investigators, companies, and review boards by clarifying what safety info must be shared and when. The guidance is effective now, aiming to keep everyone on the same page without adding extra costs or delays.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in